$KRMD
KORU Medical Systems, Inc. Stock $krmd

$krmd Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000116169722000538 Filed on November 09, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$7.345M	$7.760M	$6.041M
YoY Change	13.16%	28.47%	-0.65%
Cost Of Revenue	$3.267M	$3.438M	$2.545M
YoY Change	22.86%	35.1%	18.92%
Gross Profit	$4.078M	$4.322M	$3.496M
YoY Change	6.43%	23.65%	-11.28%
Gross Profit Margin	55.53%	55.7%	57.87%
Selling, General & Admin	$4.760M	$4.825M	$3.902M
YoY Change	-2.49%	23.67%	26.68%
% of Gross Profit	116.72%	111.64%	111.62%
Research & Development	$1.642M	$862.1K	$800.0K
YoY Change	72.85%	7.77%	105.13%
% of Gross Profit	40.26%	19.95%	22.89%
Depreciation & Amortization	$187.7K	$164.3K	$115.9K
YoY Change	65.62%	41.76%	-3.39%
% of Gross Profit	4.6%	3.8%	3.32%
Operating Expenses	$6.590M	$5.852M	$4.818M
YoY Change	10.84%	21.46%	34.58%
Operating Profit	-$2.511M	-$1.529M	-$1.322M
YoY Change	18.85%	15.69%	-467.23%
Interest Expense	$100.0K	$32.42K	-$10.12K
YoY Change	-1014.35%	-420.36%	-201.2%
% of Operating Profit
Other Income/Expense, Net		$32.42K	-$9.848K
YoY Change		-429.19%
Pretax Income	-$2.411M	-$1.497M	-$1.332M
YoY Change	66.97%	12.4%	-441.51%
Income Tax	-$434.7K	-$271.5K	-$238.1K
% Of Pretax Income
Net Earnings	-$1.977M	-$1.226M	-$1.094M
YoY Change	85.02%	12.05%	-537.51%
Net Earnings / Revenue	-26.91%	-15.79%	-18.11%
Basic Earnings Per Share		-$0.03	-$0.02
Diluted Earnings Per Share	-$0.04	-$0.03	-$24.68K
COMMON SHARES
Basic Shares Outstanding	45.28M shares	45.03M shares	44.32M shares
Diluted Shares Outstanding		45.04M shares	44.32M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$17.41M	$16.44M	$26.23M
YoY Change	-31.29%	-37.33%	-19.11%
Cash & Equivalents	$17.41M	$16.44M	$26.23M
Short-Term Investments
Other Short-Term Assets	$1.457M	$1.661M	$1.337M
YoY Change	-7.11%	24.22%	59.15%
Inventory	$6.405M	$6.884M	$6.968M
Prepaid Expenses	$1.457M	$1.661M
Receivables	$3.559M	$5.070M	$3.123M
Other Receivables	$972.4K	$686.1K	$0.00
Total Short-Term Assets	$29.80M	$30.74M	$37.66M
YoY Change	-20.15%	-18.37%	-11.7%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.887M	$3.319M	$1.291M
YoY Change	251.3%	157.05%	-15.62%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$102.6K	$88.77K	$1.585M
YoY Change	417.99%	-94.4%	328.42%
Total Long-Term Assets	$12.53M	$11.92M	$3.697M
YoY Change	215.49%	222.5%	32.99%
TOTAL ASSETS
Total Short-Term Assets	$29.80M	$30.74M	$37.66M
Total Long-Term Assets	$12.53M	$11.92M	$3.697M
Total Assets	$42.33M	$42.67M	$41.36M
YoY Change	2.52%	3.16%	-8.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.392M	$1.366M	$1.385M
YoY Change	94.85%	-1.43%	1.87%
Accrued Expenses	$2.890M	$2.569M	$2.501M
YoY Change	6.65%	2.71%	-37.48%
Deferred Revenue
YoY Change
Short-Term Debt	$433.3K	$644.7K	$673.1K
YoY Change	-14.8%	-4.22%
Long-Term Debt Due	$98.34K	$64.47K	$410.00
YoY Change		15624.39%
Total Short-Term Liabilities	$6.959M	$6.167M	$4.560M
YoY Change	45.22%	35.26%	-14.93%
LONG-TERM LIABILITIES
Long-Term Debt	$394.3K	$265.5K	$0.00
YoY Change
Other Long-Term Liabilities	$3.653M	$3.741M	$0.00
YoY Change			-100.0%
Total Long-Term Liabilities	$4.048M	$4.007M	$0.00
YoY Change			-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.959M	$6.167M	$4.560M
Total Long-Term Liabilities	$4.048M	$4.007M	$0.00
Total Liabilities	$11.01M	$10.17M	$4.560M
YoY Change	129.69%	123.12%	-16.94%
SHAREHOLDERS EQUITY
Retained Earnings	-$9.571M	-$7.594M
YoY Change	951.7%
Common Stock	$44.74M	$43.93M
YoY Change	8.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$3.844M	$3.844M
YoY Change	0.0%
Treasury Stock Shares	3.421M shares	3.421M shares
Shareholders Equity	$31.33M	$32.49M	$36.80M
YoY Change
Total Liabilities & Shareholders Equity	$42.33M	$42.67M	$41.36M
YoY Change	2.52%	3.16%	-8.96%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$1.977M	-$1.226M	-$1.094M
YoY Change	85.02%	12.05%	-537.51%
Depreciation, Depletion And Amortization	$187.7K	$164.3K	$115.9K
YoY Change	65.62%	41.76%	-3.39%
Cash From Operating Activities	$1.336M	-$2.116M	-$826.2K
YoY Change	-286.36%	156.07%	-52.52%
INVESTING ACTIVITIES
Capital Expenditures	$223.9K	-$648.9K	-$151.4K
YoY Change	-569.62%	328.69%	-70.89%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$223.9K	-$648.9K	-$151.3K
YoY Change	369.53%	328.72%	-69.73%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-145.6K	940.3K	672.5K
YoY Change	8.88%	39.81%	-119.44%
NET CHANGE
Cash From Operating Activities	1.336M	-2.116M	-826.2K
Cash From Investing Activities	-223.9K	-648.9K	-151.3K
Cash From Financing Activities	-145.6K	940.3K	672.5K
Net Change In Cash	967.0K	-1.824M	-305.1K
YoY Change	-207.62%	498.01%	-94.65%
FREE CASH FLOW
Cash From Operating Activities	$1.336M	-$2.116M	-$826.2K
Capital Expenditures	$223.9K	-$648.9K	-$151.4K
Free Cash Flow	$1.113M	-$1.467M	-$674.9K
YoY Change	-266.19%	117.35%	-44.68%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	us-gaap	Property Subject To Or Available For Operating Lease Gross PropertySubjectToOrAvailableForOperatingLeaseGross		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0000704440
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent		usd
	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets		usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
	krmd	Rou Landlord Credit RouLandlordCredit		usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities		usd
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets		usd
	krmd	Common Stock Issuance As Settlement For Litigation CommonStockIssuanceAsSettlementForLitigation		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Stock Issued1 StockIssued1		usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2022Q3	krmd	Stock Issued During Period Shares Employee Stock Ownership Plan2015 StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan2015	0	shares
CY2022Q3	krmd	Stock Issued StockIssued	0	shares
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2021Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet		usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent		usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability		usd
CY2022Q3	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P10Y1M6D
CY2021Q4	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P0Y7M6D
CY2022Q3	us-gaap	Lessee Finance Lease Renewal Term1 LesseeFinanceLeaseRenewalTerm1	P4Y10M25D
CY2021Q4	us-gaap	Lessee Finance Lease Renewal Term1 LesseeFinanceLeaseRenewalTerm1	P0Y0M0D
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	0-12305
	dei	Entity Registrant Name EntityRegistrantName	KORU MEDICAL SYSTEMS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NY
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	13-3044880
	dei	Entity Address Address Line1 EntityAddressAddressLine1	100 Corporate Drive
	dei	Entity Address City Or Town EntityAddressCityOrTown	Mahwah
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07430
	dei	City Area Code CityAreaCode	(845)
	dei	Local Phone Number LocalPhoneNumber	469-2042
	dei	Security12b Title Security12bTitle	Common stock, $0.01 par value
	dei	Trading Symbol TradingSymbol	KRMD
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	45279948	shares
	dei	Entity Listing Par Value Per Share EntityListingParValuePerShare	0.01
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	3420502	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16441268	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25334889	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	24471	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	24471	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5070077	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3592886	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	6884156	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	6106338	usd
CY2022Q3	us-gaap	Other Receivables OtherReceivables	686108	usd
CY2021Q4	us-gaap	Other Receivables OtherReceivables	718220	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1660655	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1568821	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	30742264	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	37321154	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3318612	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1106445	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	310011	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	263729	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	798534	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	808813	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3865370	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	95553	usd
CY2022Q3	krmd	Finance Lease Right Of Use Asset Amortization1 FinanceLeaseRightOfUseAssetAmortization1	23671	usd
CY2022Q3	us-gaap	Property Subject To Or Available For Operating Lease Gross PropertySubjectToOrAvailableForOperatingLeaseGross	331400	usd
CY2022Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	3520823	usd
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1941254	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	88772	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	19812	usd
CY2022Q3	us-gaap	Assets Assets	42665775	usd
CY2021Q4	us-gaap	Assets Assets	41293031	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1365610	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1227533	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2568746	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2709704	usd
CY2022Q3	us-gaap	Notes Payable Current NotesPayableCurrent	644733	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	508583	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	357491	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	90000	usd
CY2022Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	824047	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	160603	usd
CY2022Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	64467	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	342399	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	95553	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	6167493	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4791976	usd
CY2022Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	265542	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3741015	usd
CY2022Q3	us-gaap	Liabilities Liabilities	10174050	usd
CY2021Q4	us-gaap	Liabilities Liabilities	4791976	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48657023	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48044162	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	45236521	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	44623660	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	486570	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	480441	usd
CY2022Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	43443201	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	40774245	usd
CY2022Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	3420502	shares
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	3420502	shares
CY2022Q3	us-gaap	Treasury Stock Value TreasuryStockValue	3843562	usd
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3843562	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-7594484	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-910069	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	32491725	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	36501055	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	42665775	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	41293031	usd
CY2022Q3	us-gaap	Revenues Revenues	7760398	usd
CY2021Q3	us-gaap	Revenues Revenues	6040544	usd
	us-gaap	Revenues Revenues	20551356	usd
	us-gaap	Revenues Revenues	16999669	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3438036	usd
CY2021Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2544794	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	9260516	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	7061881	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	4322362	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	3495750	usd
	us-gaap	Gross Profit GrossProfit	11290840	usd
	us-gaap	Gross Profit GrossProfit	9937788	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4825349	usd
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3901830	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	15846584	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	12980604	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	862148	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	800020	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3314233	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1523739	usd
CY2022Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	164344	usd
CY2021Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	115934	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	399479	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	349822	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	5851841	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	4817784	usd
	us-gaap	Operating Expenses OperatingExpenses	19560296	usd
	us-gaap	Operating Expenses OperatingExpenses	14854165	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1529479	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1322034	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8269456	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4916377	usd
CY2022Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-10057	usd
CY2021Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-7283	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-38897	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-21761	usd
CY2021Q3	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	273	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	1009	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	42476	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2838	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	44579	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	16883	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	32419	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9848	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5682	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3869	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1497060	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1331882	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-8263774	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-4920246	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-271500	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-238104	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1579359	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1425781	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-1225560	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-1093778	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6684415	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3494465	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45038181	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44322335	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44877366	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44510021	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45038181	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44322335	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44877366	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44510021	shares
	us-gaap	Net Income Loss NetIncomeLoss	-6684415	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3494465	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2361085	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1967632	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	399479	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	349822	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-1579569	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-1440060	usd
	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	1009	usd
	krmd	Rou Landlord Credit RouLandlordCredit	218044	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1445079	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	549711	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	777818	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	138160	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	160794	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	529039	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	267491	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	138077	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	760493	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	663444	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	45684	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-140958	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-573565	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6741013	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3602378	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	2541693	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	301720	usd
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	9065	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	36003	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	25838	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2577696	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-318493	usd
	krmd	Borrowings From Indebtedness BorrowingsFromIndebtedness	644733	usd
	krmd	Borrowings From Indebtedness BorrowingsFromIndebtedness	924389	usd
	krmd	Payments On Indebtedness PaymentsOnIndebtedness	508583	usd
	krmd	Payments On Indebtedness PaymentsOnIndebtedness	251255	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	314000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1230000	usd
	krmd	Common Stock Issuance As Settlement For Litigation CommonStockIssuanceAsSettlementForLitigation	938094	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	25062	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2232	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	425088	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2838996	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-8893621	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1081875	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25334889	usd
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27315286	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16441268	usd
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26233411	usd
	us-gaap	Interest Paid Net InterestPaidNet	15700	usd
	us-gaap	Interest Paid Net InterestPaidNet	6194	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	850	usd
	krmd	Issuance Of Common Stock Compensation IssuanceOfCommonStockCompensation	355505	usd
	krmd	Issuance Of Common Stock Compensation IssuanceOfCommonStockCompensation	295947	usd
	us-gaap	Stock Issued1 StockIssued1	938094	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	36501055	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	142500	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	524670	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	170386	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2537514	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	34801097	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	115505	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	527736	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	231511	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-133158	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2921341	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	32621350	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	97501	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	514047	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	170387	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	314000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-1225560	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	32491725	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	36156979	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	56250	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	677934	usd
CY2021Q1	krmd	New Issuance Litigation Settlement Amount Issuance NewIssuanceLitigationSettlementAmountIssuance	938094	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1230000	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-1276138	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	37783119	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	97196	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	441841	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	66135	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1124549	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	37263742	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	142501	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	406414	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	79362	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-1093778	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	36798241	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_844_eus-gaap--NatureOfOperations_zHNZkbHRtgod" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_86C_z14C5aMQOXr3">NATURE OF OPERATIONS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">KORU MEDICAL SYSTEMS, INC. (the “Company,” “KORU Medical,” “we,” “us” or “our”) designs, manufactures and markets proprietary portable and innovative medical devices primarily for the subcutaneous drug delivery market as governed by the United States Food and Drug Administration (the “FDA”) quality and regulatory system and international standards for quality system management. The Company operates as <span id="xdx_907_eus-gaap--NumberOfReportableSegments_dxH_uN_c20220101__20220930_zv2xiy2bFlob" title="Number of segments::XDX::1">one</span> segment.</p>
CY2022Q3	us-gaap	Cash Uninsured Amount CashUninsuredAmount	250000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-1225560	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-1093778	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6684415	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3494465	usd
CY2022Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2021Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2022Q3	krmd	Weighted Average Number Of Shares Outstanding WeightedAverageNumberOfSharesOutstanding	45038181	shares
CY2021Q3	krmd	Weighted Average Number Of Shares Outstanding WeightedAverageNumberOfSharesOutstanding	44322335	shares
	krmd	Weighted Average Number Of Shares Outstanding WeightedAverageNumberOfSharesOutstanding	44877366	shares
	krmd	Weighted Average Number Of Shares Outstanding WeightedAverageNumberOfSharesOutstanding	44510021	shares
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84A_eus-gaap--UseOfEstimates_zkEc828m90Y4" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_86E_zAw73xtcQ6C3">USE OF ESTIMATES IN THE FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. Important estimates include but are not limited to asset lives, valuation allowances, inventory valuation, and accruals.</p>
	krmd	Schedule Of Net Sales By Geography ScheduleOfNetSalesByGeography	<p id="xdx_89A_ecustom--ScheduleOfNetSalesByGeography_zjOU89BfL0ki" style="font: 10pt Times New Roman, Times, Serif; margin: 0">The following table summarizes net sales by geography for the three and nine months ended September 30, 2022, and 2021:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; display: none; visibility: hidden"> <span id="xdx_8BF_zeUSqVVcR4Q1">Schedule of net sales by geography</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="5" style="border-bottom: black 1pt solid; text-align: center"><b>Three Months Ended September 30,</b></td> <td> </td> <td colspan="5" style="border-bottom: black 1pt solid; text-align: center"><b>Nine Months Ended September 30,</b></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>2022</b></td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>2021</b></td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>2022</b></td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>2021</b></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 94.75pt"><b>Sales</b></td> <td style="width: 8.65pt"> </td> <td style="width: 8.6pt"> </td> <td style="width: 66.5pt; text-align: right"> </td> <td style="width: 18.8pt"> </td> <td style="width: 8.6pt"> </td> <td style="width: 66.5pt; text-align: right"> </td> <td style="width: 0.25in"> </td> <td style="width: 8.6pt"> </td> <td style="width: 66.5pt; text-align: right"> </td> <td style="width: 18.8pt"> </td> <td style="width: 8.6pt"> </td> <td style="width: 66.5pt; text-align: right"> </td> <td style="width: 8.6pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #E6E6E6"> <td style="padding-left: 0.2in">Domestic</td> <td> </td> <td>$</td> <td id="xdx_988_eus-gaap--Revenues_c20220701__20220930__srt--StatementGeographicalAxis__country--US_zgZ08HjFoMEj" style="text-align: right" title="Revenues">6,661,196</td> <td> </td> <td>$</td> <td id="xdx_98F_eus-gaap--Revenues_c20210701__20210930__srt--StatementGeographicalAxis__country--US_zoBK9dNvp8D4" style="text-align: right">5,254,336</td> <td> </td> <td>$</td> <td id="xdx_980_eus-gaap--Revenues_c20220101__20220930__srt--StatementGeographicalAxis__country--US_zbvnXvMZr3h6" style="text-align: right">17,475,083</td> <td> </td> <td>$</td> <td id="xdx_980_eus-gaap--Revenues_c20210101__20210930__srt--StatementGeographicalAxis__country--US_zjlsA88o05I5" style="text-align: right">14,346,895</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.2in">International</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_98E_eus-gaap--Revenues_c20220701__20220930__srt--StatementGeographicalAxis__us-gaap--NonUsMember_zeBtmsGaXpK4" style="border-bottom: black 1pt solid; text-align: right">1,099,202</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_98E_eus-gaap--Revenues_c20210701__20210930__srt--StatementGeographicalAxis__us-gaap--NonUsMember_zM3Y4OqR09Pd" style="border-bottom: black 1pt solid; text-align: right">786,208</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_985_eus-gaap--Revenues_c20220101__20220930__srt--StatementGeographicalAxis__us-gaap--NonUsMember_zUtfFfkusvXc" style="border-bottom: black 1pt solid; text-align: right">3,076,273</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_98F_eus-gaap--Revenues_c20210101__20210930__srt--StatementGeographicalAxis__us-gaap--NonUsMember_zYV3keMeoS55" style="border-bottom: black 1pt solid; text-align: right">2,652,774</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #E6E6E6"> <td><b>Total</b></td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td id="xdx_98A_eus-gaap--Revenues_c20220701__20220930_z13AjGOKl5D7" style="border-bottom: black 2.25pt double; text-align: right">7,760,398</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td id="xdx_989_eus-gaap--Revenues_c20210701__20210930_zD8BMnphrSz3" style="border-bottom: black 2.25pt double; text-align: right">6,040,544</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td id="xdx_98F_eus-gaap--Revenues_c20220101__20220930_zFeB04nZdj0e" style="border-bottom: black 2.25pt double; text-align: right">20,551,356</td> <td style="border-bottom: white 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td id="xdx_98B_eus-gaap--Revenues_c20210101__20210930_zEdIC0oNz9F8" style="border-bottom: black 2.25pt double; text-align: right">16,999,669</td> <td> </td></tr> </table>
CY2022Q3	us-gaap	Revenues Revenues	7760398	usd
CY2021Q3	us-gaap	Revenues Revenues	6040544	usd
	us-gaap	Revenues Revenues	20551356	usd
	us-gaap	Revenues Revenues	16999669	usd
	krmd	Accounting Pronouncements Not Yet Adopted AccountingPronouncementsNotYetAdopted	<p id="xdx_84F_ecustom--AccountingPronouncementsNotYetAdopted_z2fOASz6203c" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_86A_zgHS2HDuOip8">ACCOUNTING PRONOUNCEMENTS NOT YET ADOPTED</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">In June 2016, the FASB issued ASU No. 2016-13, <i>Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</i>, which amends guidance on reporting credit losses for assets held at amortized cost basis and available for sale debt securities. For assets held at amortized cost basis, Topic 326 eliminates the probable initial recognition threshold in current GAAP and, instead, requires an entity to reflect its current estimate of all expected credit losses. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial assets to present the net amount expected to be collected. For available for sale debt securities, credit losses should be measured in a manner similar to current GAAP, however Topic 326 will require that credit losses be presented as an allowance rather than as a write-down. This ASU affects entities holding financial assets and net investment in leases that are not accounted for at fair value through net income. The amendments affect loans, debt securities, trade receivables, net investments in leases, off balance sheet credit exposures, reinsurance receivables, and any other financial assets not excluded from the scope that have the contractual right to receive cash. The amendments in this update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company is assessing the impact of the adoption of the ASU on its financial statements, disclosure requirements and methods of adoption.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The Company considers the applicability and impact of all recently issued accounting pronouncements. Recent accounting pronouncements not specifically identified in our disclosures are either not applicable to the Company or are not expected to have a material effect on our financial condition or results of operations.</p>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_846_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zcddkOSO6K9f" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_866_zjzbm2POaKC8">RECLASSIFICATION</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Certain reclassifications have been made to conform prior period data to the current presentation. These reclassifications had no effect on reported net income.</p>
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5945585	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3418479	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2626973	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2312034	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3318612	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1106445	usd
CY2022Q3	us-gaap	Construction In Progress Gross ConstructionInProgressGross	800000	usd
CY2022Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	1000000.0	usd
CY2022Q3	us-gaap	Depreciation Depreciation	130882	usd
CY2021Q3	us-gaap	Depreciation Depreciation	100502	usd
	us-gaap	Depreciation Depreciation	329526	usd
	us-gaap	Depreciation Depreciation	301469	usd
	krmd	Stock Issued During Period Shares Employee Stock Ownership Plan2015 StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan2015	295000	shares
	krmd	Stock Issued StockIssued	97100	shares
CY2021Q1	krmd	Nonemployee Services Transaction Cost NonemployeeServicesTransactionCost	75000	shares
CY2022Q3	us-gaap	Debt Instrument Frequency Of Periodic Payment DebtInstrumentFrequencyOfPeriodicPayment	Monthly payments were due on the first of each month beginning August 1, 2022 through June 1, 2023
CY2022Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	157076	usd
CY2021Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	37093	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	396658	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	112383	usd
CY2022Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	18300	usd
CY2021Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	35960	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	96588	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	104396	usd
CY2022Q3	us-gaap	Lease Cost LeaseCost	175376	usd
CY2021Q3	us-gaap	Lease Cost LeaseCost	73053	usd
	us-gaap	Lease Cost LeaseCost	493246	usd
	us-gaap	Lease Cost LeaseCost	216779	usd
CY2022Q3	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	17754	usd
CY2021Q3	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	597	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	23672	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	2188	usd
CY2022Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	1381	usd
CY2021Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	10	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	1381	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	57	usd
CY2022Q3	krmd	Finance Lease Cost FinanceLeaseCost	19135	usd
CY2021Q3	krmd	Finance Lease Cost FinanceLeaseCost	607	usd
	krmd	Finance Lease Cost FinanceLeaseCost	25053	usd
	krmd	Finance Lease Cost FinanceLeaseCost	2245	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	301150	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	105618	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	26443	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	2232	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3865370	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	95553	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	342399	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	95553	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3741015	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	4083414	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	95553	usd
CY2022Q3	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	355071	usd
CY2021Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	12725	usd
CY2022Q3	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	23671	usd
CY2021Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	-12725	usd
CY2022Q3	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	331400	usd
CY2022Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	64467	usd
CY2022Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	265542	usd
CY2022Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	330009	usd
CY2022Q3	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.0402	pure
CY2021Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.0475	pure
CY2022Q3	us-gaap	Lessee Finance Lease Discount Rate LesseeFinanceLeaseDiscountRate	0.0425	pure
CY2021Q4	us-gaap	Lessee Finance Lease Discount Rate LesseeFinanceLeaseDiscountRate	0.0475	pure
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	124876	usd
CY2022Q3	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	19832	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	499503	usd
CY2022Q3	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	79329	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	499503	usd
CY2022Q3	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	79329	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	499503	usd
CY2022Q3	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	79329	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	499503	usd
CY2022Q3	krmd	Finance Lease Liability Payments Due Year Six FinanceLeaseLiabilityPaymentsDueYearSix	79329	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2830519	usd
CY2022Q3	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	33052	usd
CY2022Q3	krmd	Lessee Operating Lease Liability Payments Due Total LesseeOperatingLeaseLiabilityPaymentsDueTotal	4953407	usd
CY2022Q3	krmd	Lessee Financing Lease Lease Liability Payments Due Total LesseeFinancingLeaseLeaseLiabilityPaymentsDueTotal	370200	usd
CY2022Q3	krmd	Lessee Operating Lease Imputed Interest LesseeOperatingLeaseImputedInterest	869993	usd
CY2022Q3	krmd	Lessee Financing Lease Imputed Interest LesseeFinancingLeaseImputedInterest	40191	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	4083414	usd
CY2022Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	330009	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001161697-22-000538-index-headers.html	Edgar Link	pending
0001161697-22-000538-index.html	Edgar Link	pending
0001161697-22-000538.txt	Edgar Link	pending
0001161697-22-000538-xbrl.zip	Edgar Link	pending
ex_31-1.htm	Edgar Link	pending
ex_31-2.htm	Edgar Link	pending
ex_32-1.htm	Edgar Link	pending
ex_32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form_10-q.htm	Edgar Link	pending
krmd-20220930.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
krmd-20220930_def.xml	Edgar Link	unprocessable
krmd-20220930_pre.xml	Edgar Link	unprocessable
form_10-q_htm.xml	Edgar Link	completed
krmd-20220930_cal.xml	Edgar Link	unprocessable
krmd-20220930_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KRMD
KORU Medical Systems, Inc. Stock $krmd

2022 Q4 Form 10-Q Financial Statement

#000116169722000538 Filed on November 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KRMD KORU Medical Systems, Inc. Stock $krmd

2022 Q4 Form 10-Q Financial Statement

#000116169722000538 Filed on November 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KRMD
KORU Medical Systems, Inc. Stock $krmd